Share
Journal Information
Most cited
Data available in articles published since the year 2014
5
Validation of an automated quality control method to test sterility of two advanced therapy medicinal products: Mesenchymal stromal cells and their extracellular vesicles
Carolina Kymie Vasques Nonaka, Zaquer Suzana Munhoz Costa-Ferro, Ana Carolina Palmeira Arraes, Thamires Lopes Weber, Luciana Souza de Aragão França, Katia Nunes Silva, Bruno Solano de Freitas Souza
Hematol Transfus Cell Ther. 2025;47: 103727
5
Full text access
5
From the mechanism of action to clinical management: A review of cardiovascular toxicity in adult treated with CAR-T therapy
Frank Nunes, Breno Moreno de Gusmão, Franciely Bueno Wiginesk, Euler Manenti, Juliana Soares, Mizianne Garcia Freitas, Juliane Dantas Seabra-Garcez, Alexandre Manoel Varela, ... Ariane Vieira Scarlatelli Macedo
Hematol Transfus Cell Ther. 2025;47: 103693
5
Full text access
5
Anti-HLA antibody formation increases the chances of platelet refractoriness in platelet-transfused patients: a systematic review with meta-analysis
Luana Joana Barreto Cabral, Daniela Pereira Lopes, Eduardo dos Santos Martins Filho, Rubenilson Caldas Valois, Paula Christine Amarantes Justino Oliveira, Patrícia Jeanne de Souza Mendonça-Mattos
Hematol Transfus Cell Ther. 2025;47: 103821
5
Full text access
4
Lack of association between the TMPRSS6 gene polymorphism (rs855791) and anemia: a comprehensive meta-analysis
Jethendra Kumar Muruganantham, Ramakrishnan Veerabathiran
Hematol Transfus Cell Ther. 2025;47: 103737
4
Full text access
3
COVID-19 Microangiopathy: Insights into plasma exchange as a therapeutic strategy
Yigit Baykara, Kaan Sevgi, Yamac Akgun
Hematol Transfus Cell Ther. 2025;47: 103963
3
Full text access
3
Annualized bleeding rate in hemophilia A patients in Brazil: a systematic review
Alessandra NL Prezotti, Débora MC Rocha, Endi L. Galvão, Thaís Gimenez, Leo Sekine, Rodrigo A. Ribeiro, Elisa Sobreira
Hematol Transfus Cell Ther. 2025;47: 103736
3
Full text access
3
Ponatinib in the treatment of patients with chronic myeloid leukemia and increased cardiovascular risk: A review of management strategies
Tomasz Sacha, Katarzyna Krawczyk
Hematol Transfus Cell Ther. 2025;47: 103675
3
Full text access
3
Hematological ratios and cytokine profiles in heterozygous beta-thalassemia
Ana Carolina Marques Ciceri, Laura Eduarda de Oliveira, Ana Luísa Richter, José Antonio Mainardi de Carvalho, Maylla Rodrigues Lucena, Guilherme Wataru Gomes, Maria Stella Figueiredo, Magnun Nueldo Nunes dos Santos, ... Clóvis Paniz
Hematol Transfus Cell Ther. 2025;47: 103845
3
Full text access
2
Diagnosis and treatment of chronic lymphocytic leukemia: 2025 recommendations of the Brazilian Group of Chronic Lymphocytic Leukemia of the Brazilian Association of Hematology and Hemotherapy (ABHH)
Carlos Sérgio Chiattone, Fernanda de Morais Marques, Valeria Buccheri, Mihoko Yamamoto, Sergio Costa Fortier, Maura Rosane Valerio Ikoma-Colturato, Nelson Hamerschlak, Vera Lucia de Piratininga Figueiredo, ... Brazilian Group of Chronic Lymphocytic Leukemia
Hematol Transfus Cell Ther. 2025;47: 103822
2
Full text access
2
Clinical characteristics and outcomes of non-tuberculous mycobacterial pulmonary infections after hematopoietic stem cell transplantation: A retrospective cohort study
Zahia Esber, Hamza Salam, Shefali Godara, Ayman Soubani
Hematol Transfus Cell Ther. 2025;47: 103841
2
Full text access
Publish in
Hematology, Transfusion and Cell Therapy
